SHH
OCTANEDIOIC ACID HYDROXYAMIDE PHENYLAMIDE
Find entries where: SHH
is present as a standalone ligand in 17 entries
Chemical Component Summary | |
---|---|
Name | OCTANEDIOIC ACID HYDROXYAMIDE PHENYLAMIDE |
Synonyms | SAHA |
Identifiers | N-hydroxy-N'-phenyl-octanediamide |
Formula | C14 H20 N2 O3 |
Molecular Weight | 264.32 |
Type | NON-POLYMER |
Isomeric SMILES | c1ccc(cc1)NC(=O)CCCCCCC(=O)NO |
InChI | InChI=1S/C14H20N2O3/c17-13(15-12-8-4-3-5-9-12)10-6-1-2-7-11-14(18)16-19/h3-5,8-9,19H,1-2,6-7,10-11H2,(H,15,17)(H,16,18) |
InChIKey | WAEXFXRVDQXREF-UHFFFAOYSA-N |
Chemical Details | |
---|---|
Formal Charge | 0 |
Atom Count | 39 |
Chiral Atom Count | 0 |
Bond Count | 39 |
Aromatic Bond Count | 6 |
Drug Info: DrugBank
DrugBank ID | DB02546 |
---|---|
Name | Vorinostat |
Groups |
|
Description | Vorinostat (rINN) or suberoylanilide hydroxamic acid (SAHA), is a drug currently under investigation for the treatment of cutaneous T cell lymphoma (CTCL), a type of skin cancer, to be used when the disease persists, gets worse, or comes back during or after treatment with other medicines. It is the first in a new class of agents known as histone deacetylase inhibitors. A recent study suggested that vorinostat also possesses some activity against recurrent glioblastoma multiforme, resulting in a median overall survival of 5.7 months (compared to 4 - 4.4 months in earlier studies). Further brain tumor trials are planned using combinations of vorinostat with other drugs. |
Synonyms |
|
Brand Names | Zolinza |
Indication | For the treatment of cutaneous manifestations in patients with cutaneous T-cell lymphoma who have progressive, persistent or recurrent disease on or following two systemic therapies. |
Categories |
|
ATC-Code | L01XH01 |
CAS number | 149647-78-9 |
Drug Targets
Name | Target Sequence | Pharmacological Action | Actions |
---|---|---|---|
Histone deacetylase 1 | MAQTQGTRRKVCYYYDGDVGNYYYGQGHPMKPHRIRMTHNLLLNYGLYRK... | unknown | inhibitor |
Histone deacetylase 2 | MAYSQGGGKKKVCYYYDGDIGNYYYGQGHPMKPHRIRMTHNLLLNYGLYR... | unknown | inhibitor |
Histone deacetylase 3 | MAKTVAYFYDPDVGNFHYGAGHPMKPHRLALTHSLVLHYGLYKKMIVFKP... | unknown | inhibitor |
Histone deacetylase 6 | MTSTGQDSTTTRQRRSRQNPQSPPQDSSVTSKRNIKKGAVPRSIPNLAEV... | unknown | inhibitor |
Histone deacetylase 8 | MEEPEEPADSGQSLVPVYIYSPEYVSMCDSLAKIPKRASMVHSLIEAYAL... | unknown | |
View More |
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison
T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS.
Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682
Related Resource References
Resource Name | Reference |
---|---|
Pharos | CHEMBL98 |
PubChem | 5311 |
ChEMBL | CHEMBL98 |
ChEBI | CHEBI:45716 |
CCDC/CSD | IQILAW, IQILAW03, IQILAW01, IQILAW02, FAKMOV |
COD | 7206988, 7206989, 7206991 |